PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes

التفاصيل البيبلوغرافية
العنوان: PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes
المؤلفون: Zhiguang Zhou, Fang Liu, Ting Zhong, Xia Li, Yuting Xie, Chao Wu, Rong Tang
المصدر: The Journal of clinical endocrinology and metabolism. 105(6)
سنة النشر: 2019
مصطلحات موضوعية: 0301 basic medicine, Blood Glucose, CD4-Positive T-Lymphocytes, Male, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Programmed Cell Death 1 Receptor, CD8-Positive T-Lymphocytes, Biochemistry, T-Lymphocytes, Regulatory, B7-H1 Antigen, 0302 clinical medicine, Endocrinology, Cytotoxic T cell, Prospective Studies, Child, biology, Chemistry, Remission Induction, Middle Aged, Prognosis, Child, Preschool, Female, Adult, medicine.medical_specialty, Adolescent, 030209 endocrinology & metabolism, Context (language use), 03 medical and health sciences, Young Adult, Immune system, Downregulation and upregulation, Internal medicine, PD-L1, medicine, Humans, Aged, Glycated Hemoglobin, Type 1 diabetes, Biochemistry (medical), Infant, medicine.disease, 030104 developmental biology, Diabetes Mellitus, Type 1, Case-Control Studies, biology.protein, Hemoglobin, CD8, Biomarkers, Follow-Up Studies
الوصف: Context Partial remission (PR) in type 1 diabetes (T1D) is accompanied by downregulation of the immune response. Programmed cell death-1 (PD-1) and its ligand (PD-L1) are important immunosuppressive molecules, but their changes in the PR phase are unclear. Objective We investigated the dynamic changes of PD-1/PD-L1 expression on T cells around the PR phase in T1D. Methods Ninety-eight T1D patients were recruited cross-sectionally and grouped according to PR status into nonremitters (individuals who did not undergo PR during the disease course; n = 39), pre-PR (n = 15), mid-PR (n = 30), and post-PR (n = 14) subgroups. PR was defined according to C-peptide level ≥300 pmol/L or index of insulin-adjusted hemoglobin A1c ≤9 as recommended. Among all the 98 patients, 29 newly diagnosed individuals were prospectively followed up for 1 year. The dynamic changes of PD-1/PD-L1 expression, frequency of regulatory T cells (Tregs) and IL-35+ Tregs among peripheral CD4/CD8+ T cells were determined. Results PD-1/PD-L1 on CD4+/CD8+ T cells showed a dynamic change around the PR phase: lowest in pre-PR phase, restored in mid-PR phase, and declined again in post-PR phase. Conversely, this pattern did not occur for nonremitters. Notably, PD-1 expression on CD8+ T cells in mid-PR was positively correlated with the length of the PR phase. The percentages of circulating Tregs and IL-35+ Tregs showed no relation to PR. Conclusions The PR phase is associated with restoration of PD-1/PD-L1 on CD4+ and CD8+ T cells, suggesting that PD-1/PD-L1 may be a potential target for prolonging this phase in T1D.
تدمد: 1945-7197
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d699b5dedc204397be237eefc4fba29Test
https://pubmed.ncbi.nlm.nih.gov/32236416Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....5d699b5dedc204397be237eefc4fba29
قاعدة البيانات: OpenAIRE